Delivery Order SPE2DB22D2006-SPE2DB26FV5WH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,949.28 to AmerisourceBergen Drug Corp for Act-O-Vials on September 18, 2025, with an ultimate completion date of September 19, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under a larger indefinite delivery vehicle. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. As a critical pharmaceutical distributor, AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $27,440.80 to AmerisourceBergen Drug Corp for Act-o-Vials on September 16, 2025, with completion targeted for September 17, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $7,146.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for ACT-O-VIALS pharmaceutical supplies, with completion targeted for April 23, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $8,642.64 to AmerisourceBergen Drug Corp for Act-O-Vials on July 28, 2025, with completion targeted for July 29, 2025. This firm fixed price delivery order represents a non-competitive award and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $6,860.20 to AmerisourceBergen Drug Corp for Act-O-Vials pharmaceutical products on September 17, 2025, with completion expected by September 18, 2025. This firm fixed-price contract, issued without a set-aside designation, represents a competitively awarded order for medical supplies to support federal healthcare operations. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $6,693.29 to AmerisourceBergen Drug Corp for ACT-O-Vials on August 19, 2025, with an ultimate completion date of August 20, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction typical of AmerisourceBergen's extensive portfolio of federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,744.08 to AmerisourceBergen Drug Corp for ACT-O-VIALS on October 22, 2025, with completion scheduled for October 23, 2025. This contract is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $13,928.80 to AmerisourceBergen Drug Corp for ACT-O-VIALS on September 29, 2025, with completion targeted for September 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a $21,606.60 delivery order to AmerisourceBergen Drug Corp for ACT-O-Vials on September 5, 2025, with an ultimate completion date of September 8, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a small transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio and reflects the company's role as a critical vendor for military...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,038.72 on October 6, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which is not set-aside restricted, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The vendor, headquartered in Conshohocken, Pennsylvania, will...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB26FV5WHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,934.93 to AmerisourceBergen Drug Corp for Act-O-Vials on October 27, 2025, with an ultimate completion date of October 28, 2025. This is a firm fixed price, non-set-aside contract performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's contract awards with the DLA demonstrate an extensive portfolio of medical product deliveries covering specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains. All of AmerisourceBergen's reviewed contract awards have been competitively awarded without set-asides, reflecting the company's capability to meet federal procurement requirements through open competition. The Defense Health Agency, U.S. Coast Guard, and other government healthcare systems are served through this flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 10/27/25 |